The Cardiac Modelling and Imaging Biomarkers (CMIB) group develops technological advances in medical imaging and computational physiological modelling in order to propose novel biomarkers that will enable a better management of cardiovascular diseases. We sit in St Thomas’ Hospital, in the heart of London.
Selecting the best therapies
How disease affects cardiac morphology, and how to use this signature to best inform therapy decisions
Identifying faulty valves in the heart
Non-invasive pressure drops
Unveiling the components of dynamic blood pressure
Prediction of atrial fibrillation recurrence
How stiff is your heart?
Key to treat cardiac disease, check our latest tech to reveal it